Renal Cancer - Results from #3180

GABRQ expression is a potential prognostic marker for patients with clear cell renal cell carcinoma. December 12, 2019

Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations. December 11, 2019

MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway. December 11, 2019

Expression of the Sonic Hedgehog pathway components in clear cell renal cell carcinoma. December 11, 2019

Identification of tumor size as the only factor associated with non-diagnostic biopsies in patients with small renal masses. December 10, 2019

Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence. December 10, 2019

Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma. December 10, 2019

Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study. December 9, 2019

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. December 9, 2019

Cytoreductive nephrectomy: does CARMENA (Cancer du Rein Metastatique Nephrectomie et Antiangiogéniques) change everything? December 9, 2019

Contrast-enhanced ultrasound in detecting wall invasion and differentiating bland from tumor thrombus during robot-assisted inferior vena cava thrombectomy for renal cell carcinoma. December 6, 2019

Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients. December 6, 2019

Characteristics of clear cell renal cell carcinoma metastases to the thyroid gland: A systematic review. December 6, 2019

Contemporary Renal Tumor Categorization With Biomarker and Translational Updates: A Practical Review. December 5, 2019

Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249). December 5, 2019

Evaluation of individual and cumulative sites of extrarenal tumor invasion in pT3a clear cell renal cell carcinoma. December 5, 2019

The screening of pivotal gene expression signatures and biomarkers in renal carcinoma. December 4, 2019

Emerging role of secreted miR-210-3p as potential biomarker for clear cell Renal Cell Carcinoma metastasis. December 4, 2019

Determinants of treatment in patients with stage IV renal cell carcinoma. December 4, 2019

Outcomes of Multi-disciplinary Management of Metastatic Renal Cell Carcinoma. December 3, 2019

Page 160 of 459